Semintra
telmisartan
Table of contents
Overview
An overview of Semintra and why it is authorised in the EU
Semintra is a veterinary medicine used in cats to reduce proteinuria (protein in the urine) and to treat high blood pressure. Proteinuria can occur with chronic (long-term) kidney disease in cats, a common disease in elderly cats characterised by a progressive deterioration of kidney function over time. High blood pressure is also a long term problem of ageing cats which can occur with chronic kidney disease, hyperthyroidism (overactive thyroid gland) and other conditions.
Authorisation details
Product details | |
---|---|
Name |
Semintra
|
Agency product number |
EMEA/V/C/002436
|
Active substance |
Telmisartan
|
International non-proprietary name (INN) or common name |
telmisartan
|
Species |
Cats
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QC09CA07
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
6
|
Date of issue of marketing authorisation valid throughout the European Union |
13/02/2013
|
Contact address |
55216 Ingelheim am Rhein |
Product information
07/12/2018 Semintra - EMEA/V/C/002436 - IB/0011
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Agents acting on the renin-angiotensin system
-
Angiotensin II antagonists, plain
Therapeutic indication
Reduction of proteinuria associated with chronic kidney disease (CKD).